4//SEC Filing
YVER ANTOINE 4
Accession 0001847903-23-000090
CIK 0001847903other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 5:01 PM ET
Size
5.7 KB
Accession
0001847903-23-000090
Insider Transaction Report
Form 4
YVER ANTOINE
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2023-05-01$4.42/sh−6,800$30,083→ 789,566 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted shares. These sales were automatic and intended to qualify under Rule 10b5-1.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.28 to $4.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861878
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 5:01 PM ET
- Size
- 5.7 KB